José Miguel Viegas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
José Miguel Viegas has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Isabel Cardoso
Cardiology Department, Hospital de Santa Marta, Lisbon, Portugal
4 shared publications- Ruben Ramos
Hospital de Santa Marta , Lisbon , Portugal
4 shared publications Rui Cruz Ferreira
Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal Department of Cardiology Hospital de Santa Marta Centro Hospitalar Universitário de Lisboa Central Lisboa Portugal
4 shared publications- André Grazina
Hospital de Santa Marta , Lisbon , Portugal
3 shared publications António Fiarresga
Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal Department of Cardiology Hospital de Santa Marta Centro Hospitalar Universitário de Lisboa Central Lisboa Portugal
3 shared publications- António Fiarresga
Hospital de Santa Marta , Lisbon , Portugal
3 shared publications
Latest Publications
- Open Access
- 31 October 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (21) , 2445
Preparticipation Cardiovascular Screening of Athletes: Current Controversies and Challenges for the Future
Sports cardiology is an evolving field in cardiology, with several topics remaining controversial. Beyond the several well-known benefits of regular exercise practice, the occurrence of adverse clinical events during sports in apparently healthy individuals, especially sudden cardiac death, and the described long-term adverse cardiac adaptations associated to high volume of exercise, remain challenging. The early identification of athletes with increased risk is critical, but the most appropriate preparticipation screening protocols are also debatable and a more personalized evaluation, considering individual and sports-related characteristics, will potentially optimize this evaluation. As the risk of major clinical events during sports is not zero, independently of previous evaluation, ensuring the capacity for cardiopulmonary resuscitation, especially with availability of automated external defibrillators, in sports arenas, is crucial for its prevention and to improve outcomes. As in other areas of medicine, application of new digital technologies, including artificial intelligence, is promising and could improve in near future several aspects of sports cardiology. This paper aims to review the methodology of athletes’ preparticipation screening, emphasizing current controversies and future challenges, in order to improve early diagnosis of conditions associated with sudden cardiac death.
- 31 October 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (21) , 2445
Open AccessPreparticipation Cardiovascular Screening of Athletes: Current Controversies and Challenges for the Future
Sports cardiology is an evolving field in cardiology, with several topics remaining controversial. Beyond the several well-known benefits of regular exercise practice, the occurrence of adverse clinical events during sports in apparently healthy individuals, especially sudden cardiac death, and the described long-term adverse cardiac adaptations associated to high volume of exercise, remain challenging. The early identification of athletes with increased risk is critical, but the most appropriate preparticipation screening protocols are also debatable and a more personalized evaluation, considering individual and sports-related characteristics, will potentially optimize this evaluation. As the risk of major clinical events during sports is not zero, independently of previous evaluation, ensuring the capacity for cardiopulmonary resuscitation, especially with availability of automated external defibrillators, in sports arenas, is crucial for its prevention and to improve outcomes. As in other areas of medicine, application of new digital technologies, including artificial intelligence, is promising and could improve in near future several aspects of sports cardiology. This paper aims to review the methodology of athletes’ preparticipation screening, emphasizing current controversies and future challenges, in order to improve early diagnosis of conditions associated with sudden cardiac death.
- Open Access
- 12 February 2024
- Published by Instituto Mexicano del Seguro Social in REC: Interventional Cardiology
- Vol. 6 (1) , 52-54
Comparaci n de los resultados a largo plazo entre las estrategias de una y m ltiples marcas de stent durante los procedimientos full metal jacket
Revista Española de Cardiología: Interventional Cardiology
- 12 February 2024
- Published by Instituto Mexicano del Seguro Social in REC: Interventional Cardiology
- Vol. 6 (1) , 52-54
Open AccessComparaci n de los resultados a largo plazo entre las estrategias de una y m ltiples marcas de stent durante los procedimientos full metal jacket
Revista Española de Cardiología: Interventional Cardiology
- Open Access
- 12 February 2024
- Published by Instituto Mexicano del Seguro Social in REC: Interventional Cardiology (English Edition)
- Vol. 6 (1)
Comparison of long-term outcomes between a single versus a multiple stent brand strategy during full metal jacket procedures
Revista Española de Cardiología: Interventional Cardiology
- 12 February 2024
- Published by Instituto Mexicano del Seguro Social in REC: Interventional Cardiology (English Edition)
- Vol. 6 (1)
Open AccessComparison of long-term outcomes between a single versus a multiple stent brand strategy during full metal jacket procedures
Revista Española de Cardiología: Interventional Cardiology
- Open Access
- 9 November 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (Supplement)
STANLEy score: a new predictive model of 3-year major adverse cardiac events following "Full Metal Jacket" using new-generation drug-eluting stents
Introduction: Percutaneous Coronary Intervention (PCI) using a "Full Metal Jacket" (FMJ) procedure (≥60 mm of continuous stent length) is often required to treat very long lesions, but its clinical efficacy and safety using contemporary drug-eluting stents (DES) remains to be determined. Objectives: To identify predictors of major adverse cardiac events (MACE) associated with FMJ using new-generation DES. We sought to develop a simple model capable of accurately predict 3-year MACE following FMJ PCI. Methods: A retrospective single-centre analysis of consecutive FMJ PCI performed between January 2015 and December 2018. Exclusion criteria were use of non-third generation DES, unsuccessful procedure and loss to follow-up. The primary endpoint was a composite of all-cause death, myocardial infarction, and target vessel revascularization. Demographic, clinical, angiographic, and procedural variables were evaluated. Logistic regression analysis was performed to determine independent predictors of outcome. Based on the results, a weighted scoring system was developed. Results: The derivation cohort included 162 patients, mean age 65.9 ± 11.1 years, 83% male. The mean stent length was 73.8 ± 12.3 mm (range 60 to 116 mm), and the average number of stents was 2.74 ± 0.74 (range 2 to 5). 30-day, 1-year and 3-year MACE were 5.5%, 12.9% and 29.0%, respectively. Multivariate analysis identified diabEtes mellitus (hazard ratio (HR) 5.92; 95% confidence interval (CI) 1.57-11.54; p=0.011), Smoking habits (HR 8.37; 95%CI 3.05-15.55; p=0.001), Acute coronary syndrome (HR 3.51; 95%CI 1.030-8.98; p=0.045), Non-right coronary artery (HR 4.38; 95%CI 1.09-7.68; p=0.038), osTial lesion (HR 10.01; 95%CI 2.91-19.14; p=0.006) and severe caLcification (HR 8.59; 95%CI 2.65-15.72; p=0.001) as independent predictors of 3-year MACE. A composite score based on these 6 variables (STANLEy score) was created, ranging from 0 to 10 (Fig.1). High acuity was verified by ROC curve analysis (AUC 0.941, p <0.001). A score ≤ 3 was associated with a reduced probability (90%) of 3-year MACE. Conclusion: The STANLEy score is a good predictive model which relies on 6 simple clinical and angiographic characteristics. This score may assist physicians in selecting high-risk patients for closer monitoring or aggressive antithrombotic strategy.Figure 1
- 9 November 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (Supplement)
Open AccessSTANLEy score: a new predictive model of 3-year major adverse cardiac events following "Full Metal Jacket" using new-generation drug-eluting stents
Introduction: Percutaneous Coronary Intervention (PCI) using a "Full Metal Jacket" (FMJ) procedure (≥60 mm of continuous stent length) is often required to treat very long lesions, but its clinical efficacy and safety using contemporary drug-eluting stents (DES) remains to be determined. Objectives: To identify predictors of major adverse cardiac events (MACE) associated with FMJ using new-generation DES. We sought to develop a simple model capable of accurately predict 3-year MACE following FMJ PCI. Methods: A retrospective single-centre analysis of consecutive FMJ PCI performed between January 2015 and December 2018. Exclusion criteria were use of non-third generation DES, unsuccessful procedure and loss to follow-up. The primary endpoint was a composite of all-cause death, myocardial infarction, and target vessel revascularization. Demographic, clinical, angiographic, and procedural variables were evaluated. Logistic regression analysis was performed to determine independent predictors of outcome. Based on the results, a weighted scoring system was developed. Results: The derivation cohort included 162 patients, mean age 65.9 ± 11.1 years, 83% male. The mean stent length was 73.8 ± 12.3 mm (range 60 to 116 mm), and the average number of stents was 2.74 ± 0.74 (range 2 to 5). 30-day, 1-year and 3-year MACE were 5.5%, 12.9% and 29.0%, respectively. Multivariate analysis identified diabEtes mellitus (hazard ratio (HR) 5.92; 95% confidence interval (CI) 1.57-11.54; p=0.011), Smoking habits (HR 8.37; 95%CI 3.05-15.55; p=0.001), Acute coronary syndrome (HR 3.51; 95%CI 1.030-8.98; p=0.045), Non-right coronary artery (HR 4.38; 95%CI 1.09-7.68; p=0.038), osTial lesion (HR 10.01; 95%CI 2.91-19.14; p=0.006) and severe caLcification (HR 8.59; 95%CI 2.65-15.72; p=0.001) as independent predictors of 3-year MACE. A composite score based on these 6 variables (STANLEy score) was created, ranging from 0 to 10 (Fig.1). High acuity was verified by ROC curve analysis (AUC 0.941, p <0.001). A score ≤ 3 was associated with a reduced probability (90%) of 3-year MACE. Conclusion: The STANLEy score is a good predictive model which relies on 6 simple clinical and angiographic characteristics. This score may assist physicians in selecting high-risk patients for closer monitoring or aggressive antithrombotic strategy.Figure 1
- Open Access
- 23 October 2023
- Published by MDPI AG in Cardiogenetics
- Vol. 13 (4) , 145-153
Sudden Cardiac Death in Biventricular Arrhythmogenic Cardiomyopathy: A New Undescribed Variant of the MYH6 Gene
Arrhythmogenic cardiomyopathy (ACM) may present with sudden cardiac arrest (SCA), and demonstration of a pathogenic variant in ACM-related genes is crucial for its definitive diagnosis. A 42-year-old female patient with family history of sudden cardiac death (SCD) was referred to the cardiomyopathy clinic after two episodes of aborted SCA. In the second episode, the patient was transported under cardiopulmonary resuscitation (downtime of 57 min) until extracorporeal membrane oxygenation was implanted. A thorough diagnostic work-up led to a diagnosis of biventricular ACM. Genetic testing revealed a previously undescribed variant in ACM patients in the MYH6 gene, c.3673G>T p.(Glu 1225*), which inserts a premature stop codon. This was considered a possible pathogenic variant originating a truncated protein, previously undescribed in ACM. The patient’s 23-year-old daughter was positive for the MYH6 variant and had ECG abnormalities suggestive of ACM. This case details the complex differential diagnosis of SCA and explores the current recommendations for the diagnosis of biventricular ACM. The identification of a MYH6 variant in a patient with ACM, recurrent SCA, and family history of SCD appears to support the hypothesis of the pathogenicity of MYH6 variants in ACM, in which the association of phenotype with sarcomere variants is still unclear.
- 23 October 2023
- Published by MDPI AG in Cardiogenetics
- Vol. 13 (4) , 145-153
Open AccessSudden Cardiac Death in Biventricular Arrhythmogenic Cardiomyopathy: A New Undescribed Variant of the MYH6 Gene
Arrhythmogenic cardiomyopathy (ACM) may present with sudden cardiac arrest (SCA), and demonstration of a pathogenic variant in ACM-related genes is crucial for its definitive diagnosis. A 42-year-old female patient with family history of sudden cardiac death (SCD) was referred to the cardiomyopathy clinic after two episodes of aborted SCA. In the second episode, the patient was transported under cardiopulmonary resuscitation (downtime of 57 min) until extracorporeal membrane oxygenation was implanted. A thorough diagnostic work-up led to a diagnosis of biventricular ACM. Genetic testing revealed a previously undescribed variant in ACM patients in the MYH6 gene, c.3673G>T p.(Glu 1225*), which inserts a premature stop codon. This was considered a possible pathogenic variant originating a truncated protein, previously undescribed in ACM. The patient’s 23-year-old daughter was positive for the MYH6 variant and had ECG abnormalities suggestive of ACM. This case details the complex differential diagnosis of SCA and explores the current recommendations for the diagnosis of biventricular ACM. The identification of a MYH6 variant in a patient with ACM, recurrent SCA, and family history of SCD appears to support the hypothesis of the pathogenicity of MYH6 variants in ACM, in which the association of phenotype with sarcomere variants is still unclear.
- Open Access
- 26 September 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 43 (2) , 87-89
Developments in sports cardiology: The way to a brighter future
- 26 September 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 43 (2) , 87-89
Open AccessDevelopments in sports cardiology: The way to a brighter future
- 9 September 2023
- Published by Elsevier in Journal of Science and Medicine in Sport
- Vol. 26 (10) , 530-532
Cardiovascular pre-participation screening in female athletes: Should it be revisited?
- 9 September 2023
- Published by Elsevier in Journal of Science and Medicine in Sport
- Vol. 26 (10) , 530-532
Cardiovascular pre-participation screening in female athletes: Should it be revisited?
- Open Access
- 7 July 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 43 (1) , 13-19
Permanent pacemaker implantation after alcoholic septal ablation induced complete heart block: Long-term impact
- 7 July 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 43 (1) , 13-19
Open AccessPermanent pacemaker implantation after alcoholic septal ablation induced complete heart block: Long-term impact
- Open Access
- 20 June 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (10) , 847-855
Intracardiac echocardiography-guided left atrial appendage occlusion: The path to independence
- 20 June 2023
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (10) , 847-855
Open AccessIntracardiac echocardiography-guided left atrial appendage occlusion: The path to independence
- Open Access
- 24 April 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 7 (5) , ytad212
Threading the needle: a case report of double-wiring technique and double intracoronary imaging guidance for a multifenestrated iatrogenic coronary artery dissection
Background: Iatrogenic coronary artery dissection (ICAD) may represent a serious complication of percutaneous coronary intervention. Stenting the dissected segment is recommended in large dissections with compromised distal blood flow, although wiring the true lumen is often difficult. Case summary: A 64-year-old woman with effort angina was submitted to invasive coronary angiography that revealed a severe stenosis in the distal right coronary artery. A large spiral ICAD occurred after pre-dilatation and guidewire position is lost. We report the treatment of this multifenestrated dissection using combined intracoronary imaging guidance with angiographic co-registered optical coherence tomography and real-time intravascular ultrasound, which were crucial to achieve a successful outcome. Discussion: A double-wiring technique with double intracoronary imaging guidance enables a comprehensive depiction of the compromised artery and should be considered in selected cases to guide true lumen wiring and stent implantation.
- 24 April 2023
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 7 (5) , ytad212
Open AccessThreading the needle: a case report of double-wiring technique and double intracoronary imaging guidance for a multifenestrated iatrogenic coronary artery dissection
Background: Iatrogenic coronary artery dissection (ICAD) may represent a serious complication of percutaneous coronary intervention. Stenting the dissected segment is recommended in large dissections with compromised distal blood flow, although wiring the true lumen is often difficult. Case summary: A 64-year-old woman with effort angina was submitted to invasive coronary angiography that revealed a severe stenosis in the distal right coronary artery. A large spiral ICAD occurred after pre-dilatation and guidewire position is lost. We report the treatment of this multifenestrated dissection using combined intracoronary imaging guidance with angiographic co-registered optical coherence tomography and real-time intravascular ultrasound, which were crucial to achieve a successful outcome. Discussion: A double-wiring technique with double intracoronary imaging guidance enables a comprehensive depiction of the compromised artery and should be considered in selected cases to guide true lumen wiring and stent implantation.